Doctors told not to routinely prescribe molnupiravir for mild COVID-19
GPs are being advised against the routine use of molnupiravir to treat patients with mild COVID-19 following evidence the antiviral failed to reduce deaths or…
GPs are being advised against the routine use of molnupiravir to treat patients with mild COVID-19 following evidence the antiviral failed to reduce deaths or…
A leading infectious diseases expert has urged health authorities to rethink their stance on the COVID-19 treatment sotrovimab, with new evidence suggesting it may outperform…
The Federal Government is tweaking the ‘existing-relationship’ rule for telehealth again, making an exemption for patients who have tested positive to COVID-19 within the previous…
GPs may soon be able to dispense COVID-19 antivirals directly to their patients after the PBAC signed off on an RACGP proposal for a new…
Molnupiravir does not appear to reduce deaths or hospitalisation in high-risk vaccinated adults with COVID-19 compared with usual care, according to the largest randomised trial…
Respiratory syncytial virus is a single-stranded RNA virus which causes infection of the respiratory tract. Discovered in 1956, it is one of the most common…
Half of Victoria’s cases have been acquired locally, doctors warn.
The pharmacy guild is petitioning state and territory governments to override the TGA's scheduling.
Drug use is not a reason to withhold therapy; it just means patients need good support and monitoring, say researchers.
On 23 July, the WHO’s Director-General, Dr Tedros Adhanom Ghebreyesus (PhD), took the unprecedented step and declared the monkeypox outbreak a “public health emergency of…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.